I. Executive Summary
This report identifies the actionable misstatements supporting Lead
Plaintiff's §10(b) and Rule 10b-5 claims in a putative class action
against Hyperion Technologies, Inc. and its CEO and CFO. The
proposed class period runs from April 30, 2024 (Q1 2024 earnings
call) through December 12, 2024, when an 8-K filing disclosed
sharply revised Q4 guidance and a Q3 ARR restatement. Hyperion
common stock declined 38% on the disclosure day, erasing
approximately $1.42 billion in market capitalization.
The engine cross-indexed 217 public statements (transcripts, press
releases, SEC filings, investor conferences) against 8,032 pages of
contemporaneous internal records (board materials, finance memos,
sales forecasts, customer success ops reviews). Four misstatements
were identified where the public statement is materially at odds
with a specific internal document dated within days of the
statement. Each pair supports a strong inference of scienter under
15 U.S.C. §78u-4(b)(2).
Key findings
- Four actionable misstatement pairs
identified across the class period, each tied to a named officer
(CEO or CFO).
- Median proximity: 4.8 days between
the public statement and the contradicting internal record.
- Centerpiece (M-04): CEO told Q3
call there was "no measurable softness in enterprise demand" seven
days after the CFO walked the Audit Committee through pipeline
coverage at the lowest level since Q1 2022.
- Disclosure-day stock move (-38%)
is statistically significant on a single-factor model controlling
for sector and market returns (t-stat 9.2).
Class-period statistics
| Class period | 2024-04-30 to 2024-12-12 |
| Class period length | 226 days |
| Public statements indexed | 217 |
| Internal records analyzed | 8,032 pp |
| Stock price decline on disclosure | -38.0% |
| Approximate market cap loss | $1.42B |
II. Misstatements Timeline
The engine ranked candidate misstatements by (i) proximity of the
contradicting internal record, (ii) seniority of the internal
source, and (iii) specificity of the falsifiable claim. The four
pairs below cleared all three thresholds. Detailed side-by-side
comparisons appear in Sections III and IV.
| Code | Public statement | Contradicting internal record | Days apart |
| M-01 | Q1 2024 earnings call
2024-04-30 · CEO, prepared remarks | VP Sales weekly forecast
2024-04-27 | 3 |
| M-02 | $120M ARR milestone press release
2024-08-07 · Corporate communications | Finance close memo (CFO)
2024-08-05 | 2 |
| M-03 | Investor conference
2024-09-12 · CFO, fireside chat | Customer success ops review
2024-09-05 | 7 |
| M-04 | Q3 2024 earnings call
2024-10-28 · CEO, prepared remarks | Board Audit Committee deck
2024-10-21 | 7 |
Median proximity across the four pairs: 4.8 days. The shortest
proximity (M-02, 2 days) is also the only pair where the public
statement is a written press release rather than an oral remark, so
the timing argument is not affected by drafting lag.
III. Side-by-Side Comparisons
Part 1 · Class-period opening through Q3 milestone
M-01 · Q1 2024 earnings call · April 30, 2024 3 days apart
Public statement
2024-04-30 · CEO, prepared remarks
“We have not seen any meaningful slippage in our enterprise renewal book, and bookings velocity is accelerating into Q2.”
Tr. 4/30/24 · p.6
Contradicting internal record
2024-04-27 · VP Sales to CFO and CRO
“Two flagship renewals slipping to Q3. Commit revised down 12% week-over-week. Discount approvals running 2x trailing quarter.”
HYP-COR-3104 · p.2
M-02 · $120M ARR milestone press release · August 7, 2024 2 days apart
Public statement
2024-08-07 · Corporate communications
“Hyperion has crossed the $120M ARR milestone, demonstrating sustained organic growth and customer expansion across all enterprise verticals.”
HYP-PR-0089
Contradicting internal record
2024-08-05 · CFO to Audit Committee chair
“To land the $120M milestone, we pulled forward $4.3M of FY25 deferred revenue. Q3 organic ARR is tracking -1.8% sequentially.”
HYP-FIN-1822 · p.4
III. Side-by-Side Comparisons (continued)
Part 2 · Investor conference through Q3 earnings call
M-03 · Q3 investor conference · September 12, 2024 7 days apart
Public statement
2024-09-12 · CFO, fireside chat
“Net retention is at 119%, and we are not seeing any signs of customer churn beyond normal seasonal patterns.”
Tr. 9/12/24 · p.11
Contradicting internal record
2024-09-05 · VP Customer Success to CFO
“Gross retention at 87.4%, lowest in 8 quarters. Logo churn +43% YoY. Two top-10 accounts in active dispute over renewal terms.”
HYP-CSO-0641 · p.3
M-04 · Q3 2024 earnings call · October 28, 2024 7 days apart
Public statement
2024-10-28 · CEO, prepared remarks
“We are seeing no measurable softness in enterprise demand, and the Q4 pipeline is the strongest in company history.”
Tr. 10/28/24 · p.4
Contradicting internal record
2024-10-21 · CFO to Audit Committee
“Enterprise pipeline coverage at 0.71x, lowest since Q1 2022. Two top-10 accounts have signaled deferral.”
HYP-BOD-0042 · p.11
IV. Source Register
Every cite in Sections II and III traces to a specific Bates-stamped
page in the productions below. Class-period scope: 2024-04-30 to
2024-12-12, inclusive of the corrective 8-K filing.
| Bates range | Custodian | Type | Pages | Produced |
| HYP-PUB-0001 to 0218 | Hyperion · Public materials | Earnings call transcripts, press releases, investor conference decks (class period) | 218 | 2024-12-30 |
| HYP-SEC-0001 to 0094 | Hyperion · SEC filings | 10-Q (Q1 to Q3 2024), 10-K (FY2023), 8-K (Dec 2024 corrective disclosure) | 94 | 2024-12-30 |
| HYP-BOD-0001 to 0184 | Hyperion · Board materials | Board books, audit committee decks, finance memos (class period) | 184 | 2025-02-12 |
| HYP-COR-0001 to 4280 | Hyperion · Officer email production | CEO, CFO, VP Sales, VP Customer Success email (April to December 2024) | 4,280 | 2025-03-08 |
| HYP-FIN-0001 to 2412 | Hyperion · Finance and accounting | Close memos, deferred revenue ledger, ARR build-back, forecasting models | 2,412 | 2025-03-22 |
| HYP-CSO-0001 to 0844 | Hyperion · Customer success ops | Retention reports, customer health scores, churn and at-risk analyses | 844 | 2025-03-22 |
| Total pages reviewed | 8,032 | |
V. Next steps (reserved)
The engine recommends Phase 2 work on (i) loss causation event-study
modeling around the December 12, 2024 disclosure, (ii) the M-02
deferred-revenue pull-forward as a potential GAAP violation
supporting a §11 Securities Act claim, and (iii) a confidential
witness outreach plan targeting members of the Audit Committee
briefed on October 21, 2024.
End of document. 4 actionable misstatements identified; 8,032 pages reviewed across 6 production custodians; every cited statement and internal record traceable to source.